The treatment hierarchy:
Tier 1 — Daily non-hormonal care (foundational for everyone)
This is the baseline. Every woman experiencing menopausal intimate symptoms benefits from consistent daily care, and many find this alone is sufficient for mild-to-moderate dryness.
- Intimate moisturizers: Hyaluronic acid-based products like V Majestic provide deep hydration that builds over time. Apply nightly for best results.
- pH-balanced cleansers: V Happy Everyday maintains the acidic environment your tissue needs for natural moisture and microbiome health.
- Lifestyle support: Hydration, omega-3s, phytoestrogen-rich foods (flaxseed, soy, lentils), pelvic floor exercises.
Results: noticeable improvement within 2-4 weeks for mild symptoms. May be the only intervention needed.
Tier 2 — Phytoestrogens and botanical support (non-hormonal but bioactive)
Phytoestrogens are plant compounds that have weak estrogen-like effects in the body. They don't replicate hormone therapy but can provide meaningful tissue support without synthetic hormones.
- Pueraria Mirifica: A clinically studied Thai botanical, included in V Majestic. Supports tissue elasticity, thickness, and natural moisture.
- Soy isoflavones: Dietary or supplemental sources may provide systemic support.
- Sea buckthorn oil: Some studies show benefit for vaginal dryness.
Results: gradual improvement over 4-8 weeks. Suitable for women who prefer to avoid hormones, have hormone-sensitive conditions, or as a step before pharmaceutical options.
Tier 3 — Topical (local) hormonal therapy
Vaginal estrogen delivered as cream, tablet, or ring. Acts locally on vaginal tissue with minimal systemic absorption.
- Vaginal estrogen cream (e.g., Estrace, Premarin)
- Vaginal estrogen tablets (e.g., Vagifem, Yuvafem)
- Vaginal estrogen ring (Estring)
- Intravaginal DHEA (Intrarosa)
Results: highly effective for moderate-severe GSM. Symptom improvement typically within 2-4 weeks. Considered safe for most women, including many breast cancer survivors (consult your oncologist).
Tier 4 — Systemic hormone therapy and oral options
For women with broader menopausal symptoms (hot flashes, mood changes, sleep disruption), systemic options may address GSM as part of a wider treatment plan.
- Oral or transdermal hormone therapy (estrogen +/- progesterone)
- Ospemifene (Osphena) — oral selective estrogen receptor modulator
- Compounded bioidentical hormones (proceed cautiously — quality varies)
Results: addresses both intimate and systemic menopausal symptoms. Requires careful evaluation of cardiovascular, breast, and endometrial risk factors.
Tier 5 — Procedure-based therapies
- Vaginal laser therapy (MonaLisa Touch, FemTouch)
- Radiofrequency therapy
Results: emerging evidence for tissue regeneration. Generally considered for women who don't tolerate or respond to other options.
How these combine:
Many women use multiple tiers simultaneously. A common effective pattern is:
- Daily V Happy Everyday + V Majestic (Tier 1-2)
- Topical vaginal estrogen 2-3x weekly (Tier 3)
- Lubricant during intimacy as needed
The non-hormonal foundation isn't replaced by medical treatment — it complements it.
What to discuss with your provider:
- Severity and impact of symptoms
- Personal and family history of breast/uterine/blood-clot conditions
- Other medications (especially aromatase inhibitors if breast cancer history)
- Lifestyle factors and preferences
- Trial timeline — most options need 2-4 weeks to assess response
When intimate symptoms of menopause appear, women face a confusing landscape of treatment options — and a lot of competing advice. Topical estrogen vs systemic hormone therapy. Pharmaceutical vs natural. Daily moisturizers vs hormonal interventions. The right choice depends on your symptom severity, medical history, personal preferences, and what your provider recommends. Here's a clear breakdown of every category, what each does, and how they fit together.
Key Takeaways
- 5 tiers of options: daily care, phytoestrogens, topical hormones, systemic hormones, procedures Daily non-hormonal care (V Happy + V Majestic) is foundational for everyone Most women benefit from combining tiers — they're not mutually exclusive Topical vaginal estrogen is highly effective for moderate-severe GSM Many breast cancer survivors can safely use topical estrogen — discuss with oncologist Give any new approach 2-4 weeks before assessing whether it's working The right choice depends on severity, medical history, and personal preference